Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual ... Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a pipeline of therapeutic assets targeting oncology indications. It also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin resistant endometrial cancer. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 4.32 | 4.32 | 3.93 | 8468 | 4.23573506 | CS |
| 4 | 0.17 | 4.09638554217 | 4.15 | 4.32 | 3.81 | 11087 | 4.13470733 | CS |
| 12 | 0.535 | 14.1347424042 | 3.785 | 4.65 | 3.58 | 23203 | 4.06787763 | CS |
| 26 | 0.12 | 2.85714285714 | 4.2 | 5.2 | 2.78 | 19339 | 3.98005427 | CS |
| 52 | 0.82 | 23.4285714286 | 3.5 | 5.2 | 2.78 | 12408 | 3.996294 | CS |
| 156 | -5.98 | -58.0582524272 | 10.3 | 12.5 | 2.40101 | 45364 | 7.0536132 | CS |
| 260 | -11.58 | -72.8301886792 | 15.9 | 58.5 | 2.40101 | 825874 | 28.0186426 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
